In The News Posted March 4, 2019 Share Posted March 4, 2019 PARSIPPANY, N.J., March 4, 2019 /PRNewswire/ -- Evonik today signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business' EBITDA. The transaction is subject to approval by the authorities in... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.